The role of glycemia in acute heart failure patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/cclm-2014-0239PMID 24988247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort.

  2013cited by this paper
• Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality.

  2012cited by this paper
• Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes

  2012cited by this paper
• Advanced Glycation Endproduct Crosslinking in the Cardiovascular System

  2012cited by this paper
• Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

  2011cited by this paper
• Hyperglycemia and Acute Coronary Syndrome: A Systematic Review of Hyperglycemia's Impact on ACS

  2010cited by this paper
• Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement

  2010cited by this paper
• Insulin resistance and acute coronary syndrome.

  2010cited by this paper
• Routine Laboratory Results and Thirty Day and One-Year Mortality Risk Following Hospitalization with Acute Decompensated Heart Failure

  2010cited by this paper
• Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.

  2010cited by this paper
• Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients.

  2010cited by this paper
• Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

  2010cited by this paper
• Impact of diabetes mellitus on survival in South East Asian patients with congestive heart failure due to left ventricular systolic dysfunction.

  2010cited by this paper
• Do Cardioselective β-Adrenoceptor Antagonists Reduce Mortality in Diabetic Patients with Congestive Heart Failure?

  2009cited by this paper
• Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*

  2009cited by this paper
• Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.

  2009cited by this paper
• Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.

  2009cited by this paper
• Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention

  2009cited by this paper
• Postoperative hyperglycaemia--are the patients diabetic?

  2009cited by this paper
• Elevated Admission Glucose and Mortality in Elderly Patients Hospitalized With Heart Failure

  2009cited by this paper
• Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk

  2008cited by this paper
• Diabetes, left ventricular systolic dysfunction, and chronic heart failure.

  2008cited by this paper
• Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.

  2008cited by this paper
• Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

  2008cited by this paper
• Heart failure-related hospitalization in the U.S., 1979 to 2004.

  2008cited by this paper
• PARP mediates structural alterations in diabetic cardiomyopathy.

  2008cited by this paper
• Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

  2008cited by this paper
• Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk

  2007cited by this paper
• Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.

  2007cited by this paper
• In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.

  2007cited by this paper
• Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

  2007cited by this paper
• Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

  2007cited by this paper
• Predictors of mortality and morbidity in patients with chronic heart failure.

  2006cited by this paper
• Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure.

  2006cited by this paper
• Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

  2006cited by this paper
• Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.

  2006cited by this paper
• EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

  2006cited by this paper
• Insulin resistance in nondiabetic patients with acute myocardial infarction.

  2006cited by this paper
• Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure

  2006cited by this paper
• Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.

  2005cited by this paper
• Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes

  2005cited by this paper
• Postprandial hyperglycemia and diabetes complications: is it time to treat?

  2005cited by this paper
• Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study

  2005cited by this paper
• Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.

  2005cited by this paper
• Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.

  2005cited by this paper
• Acute Heart Failure Syndromes: Current State and Framework for Future Research

  2005cited by this paper
• Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.

  2005cited by this paper
• Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study

  2005cited by this paper
• Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

  2005cited by this paper
• Uncoupling proteins in human heart.

  2004cited by this paper
• Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.

  2004cited by this paper
• Blood glucose and risk of cardiovascular disease in the Asia Pacific region.

  2004cited by this paper
• A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction.

  2004cited by this paper
• Postprandial glucose regulation and diabetic complications.

  2004cited by this paper
• Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients.

  2004cited by this paper
• PKC-α regulates cardiac contractility and propensity toward heart failure

  2004cited by this paper
• PKC-alpha regulates cardiac contractility and propensity toward heart failure.

  2004cited by this paper
• Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

  2003cited by this paper
• Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.

  2003cited by this paper
• Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.

  2003cited by this paper
• Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.

  2003cited by this paper
• Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.

  2003cited by this paper
• The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications

  2003cited by this paper
• The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.

  2003cited by this paper
• The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia.

  2003cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2002cited by this paper
• Role of hyperglycemia in nitrotyrosine postprandial generation.

  2002cited by this paper
• Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats.

  2002cited by this paper
• Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence

  2001cited by this paper
• IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress.

  2001cited by this paper
• Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

  2001cited by this paper
• Myocardial Cell Death in Human Diabetes

  2000cited by this paper
• Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

  2000cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.

  2000cited by this paper
• The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

  1999cited by this paper
• Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course

  1999cited by this paper
• Metabolic disturbances in diabetic cardiomyopathy

  1998cited by this paper
• Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study

  1997cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Regulation of contractile proteins in diabetic heart.

  1997cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.

  1996cited by this paper
• Glucose modulation of ischemic brain injury: review and clinical recommendations.

  1996cited by this paper
• Chart reviews in emergency medicine research: Where are the methods?

  1996cited by this paper
• Alterations in carbohydrate metabolism during stress: a review of the literature.

  1995cited by this paper
• Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

  1994cited by this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cited by this paper
• Insulin action on glucose transport in isolated cardiac myocytes: signalling pathways and diabetes-induced alterations.

  1990cited by this paper
• Changes in Substrate Metabolism and Effects of Excess Fatty Acids in Reperfused Myocardium

  1988cited by this paper
• Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.

  1988cited by this paper
• Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats.

  1988cited by this paper
• Changes in Extra- and Intracellular pH in the Brain during and following Ischemia in Hyperglycemic and in Moderately Hypoglycemic Rats

  1986cited by this paper
• Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.

  1986cited by this paper
• Pathomorphologic aspects of muscular tissue in diabetes mellitus.

  1984cited by this paper
• Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction.

  1983cited by this paper
• Physiological and metabolic correlations in human sepsis. Invited commentary.

  1979cited by this paper

• Targeting galectin-3 in cancer by novel and unique inhibitors of non-carbohydrate origin

  2025cites this paper
• Potential clinical biomarkers and perspectives in diabetic cardiomyopathy

  2023cites this paper
• Assessment of relationship between galectin-3 and ambulatory ECG-based microvolt T-wave alternans in sustained systolic-diastolic hypertension patients

  2016cites this paper
• Galectin-3 and heart failure: prognosis, prediction & clinical utility.

  2015cites this paper
• Prognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patients

  2015cites this paper